Prognostic impact of SMARCA4 deficiency and STK11 co-mutations on non-small cell lung cancer treated with immune checkpoint inhibitors.
Authors: Ying Han
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e20511
Source:
Full article
Abstract
e20511